We develop treatment methods with unique properties in the therapeutic fields of migraine and pain related to cancer.
Download the Company Description.
Klaria AB and Purdue Pharma (Canada) today announce they have entered into exclusive development and license and supply agreements for KL-00514 (Naloxone Buccal...
Year end report 2017
Annual Report 2017
We are using cookies to optimize your browsing experience. By continuing your browsing you consent to such use.